Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report

BACKGROUND: Currently, the mainstay of chronic eosinophilic pneumonia (CEP) treatment is corticosteroids, usually with a favorable response and good prognosis. However, relapse is common, requiring long-term use of corticosteroids, with risk of significant treatment-related complications. The dire n...

Descripción completa

Detalles Bibliográficos
Autores principales: Izhakian, Shimon, Pertzov, Barak, Rosengarten, Dror, Kramer, Mordechai R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254203/
https://www.ncbi.nlm.nih.gov/pubmed/35949821
http://dx.doi.org/10.12998/wjcc.v10.i18.6105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254203/
https://www.ncbi.nlm.nih.gov/pubmed/35949821
http://dx.doi.org/10.12998/wjcc.v10.i18.6105

Ejemplares similares